Severe asthma affects relatively few asthma patients, but is responsible for disproportionate asthma-related morbidity, mortality and use of healthcare resources. AAFA’s severe asthma patient survey showed that 77% of severe asthma patients surveyed had visited the emergency department at least once for a severe asthma attack.
Long-term treatment with oral corticosteroids for severe asthma can lead to both mild and serious side-effects. The longer a patient takes higher doses of these medicines, the greater the chance of side-effects. Side-effects include (but are not limited to): muscle weakness, osteoporosis, high blood pressure, eye problems, dizziness, headaches, trouble sleeping, diabetes, risk of infection, and acne.
Clinical trials have shown bronchial thermoplasty has made a major difference in the lives of severe asthma patients by reducing their asthma symptoms, asthma attacks, and trips to the emergency room. Read patient stories at AAFA’s Online Community at Inspire. Immunoglobulin E (IgE) therapy can reduce the risk of severe asthma attack in patients who have allergic asthma by preventing symptoms in a patient exposed to the allergen. This may help a severe asthma patient better control his or her asthma.